Yu Yan
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 8
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 11
- Neurology top 5%
- Developmental Neuroscience top 10%
- Inorganic Chemistry top 5%
-
- Blood Pressure and Hypertension Studies 22
- Cardiovascular Health and Disease Prevention 12
-
- Cancer-related molecular mechanisms research 12
-
- Sodium Intake and Health 11
-
- Phytochemistry and Biological Activities 11
-
- Birth, Development, and Health 9
- Journals
- Journal of Clinical Hypertension (5 papers)Phytochemistry (5 papers)Journal of Ethnopharmacology (5 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yu Yan
211 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 166
- Biological Psychiatry 121
- Nephrology 231
- Neurology 159
- Developmental Neuroscience 74
- Inorganic Chemistry 246
Countries citing papers authored by Yu Yan
This map shows the geographic impact of Yu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yan more than expected).
Fields of papers citing papers by Yu Yan
This network shows the impact of papers produced by Yu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yan. The network helps show where Yu Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 10 | |
| 6 | Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome | 2020 | 1 |
| 7 | DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model | 2020 | 0 |
| 8 | The Long-Term Outcomes and Predictors of Microvascular Decompression with or without Partial Sensory Rhizotomy for Trigeminal Neuralgia | 2020 | 2 |
| 9 | Value of Partial Sensory Rhizotomy in the Microsurgical Treatment of Trigeminal Neuralgia Through Retrosigmoid Approach | 2020 | 1 |
| 10 | Long Non-Coding RNA MALAT1 as a Detection and Diagnostic Molecular Marker in Various Human Cancers: A Pooled Analysis Based on 3255 Subjects | 2020 | 0 |
| 11 | Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer | 2019 | 6 |
| 12 | 2019 | 18 | |
| 13 | Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways | 2019 | 2 |
| 14 | 2019 | 36 | |
| 15 | The Therapeutic Effect of Melatonin on GC by Inducing Cell Apoptosis and Autophagy Induced by Endoplasmic Reticulum Stress | 2019 | 1 |
| 16 | Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer | 2018 | 3 |
| 17 | Silica nanoparticles induce autophagy dysfunction via lysosomal impairment and inhibition of autophagosome degradation in hepatocytes | 2017 | 4 |
| 18 | Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice | 2017 | 1 |
| 19 | Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma | 2016 | 2 |
| 20 | Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime | 2015 | 3 |
About Yu Yan
Yu Yan is a scholar working on Biological Psychiatry, Nephrology, Pharmacology, Behavioral Neuroscience and Cancer Research, having authored 233 papers that have together received 3.0k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (22 papers), Cardiovascular Health and Disease Prevention (12 papers), Cancer-related molecular mechanisms research (12 papers), Sodium Intake and Health (11 papers), Phytochemistry and Biological Activities (11 papers), Chronic Kidney Disease and Diabetes (11 papers), Birth, Development, and Health (9 papers) and Tryptophan and brain disorders (8 papers). The work is most often cited by research in Biological Psychiatry (121 citations), Nephrology (231 citations), Neurology (159 citations), Developmental Neuroscience (74 citations) and Inorganic Chemistry (246 citations). Yu Yan has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Junkuo Gao, Changqing Li, Qichun Zhang, Yuhang Wu, Jun He, Jie‐Kun Xu, Guanhua Du, Cong‐Yuan Xia, Wei‐Ku Zhang and Wenwen Lian. Their work appears in journals such as Journal of Clinical Hypertension, Phytochemistry, Journal of Ethnopharmacology, Scientific Reports and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.